Brainsway (BWAY) Gains from Equity Investments (2025 - 2026)
Brainsway (BWAY) posted quarterly Gains from Equity Investments of -$8.5 million for Q1 2026, down 289.55% on a QoQ basis from -$2.2 million in Q4 2025.
Brainsway (BWAY) Gains from Equity Investments (2025 - 2026) Analysis & Trends
Brainsway (BWAY) has reported Gains from Equity Investments for 2 consecutive years, with -$8.5 million the latest figure, recorded in Q1 2026.
- Quarterly Gains from Equity Investments changed N/A year-over-year to -$8.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$23.0 million (changed N/A YoY) and the FY2025 annual result came in at -$14.5 million, changed N/A from the prior year.
- Gains from Equity Investments eased to -$8.5 million in Q1 2026 per BWAY's latest filing, from -$2.2 million in the prior quarter.
- Over the last five years, Gains from Equity Investments for BWAY reached as high as -$2.2 million in Q4 2025 and fell as low as -$8.5 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn |
| 2 | Stryker | 129.01 Bn | 126.14 Bn | 3.81 Bn |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.40 Bn | 44.73 Bn | 1.29 Bn |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.46 Bn | 22.33 Bn | 2.07 Bn |
| 10 | Brainsway | 588.70 Mn | 528.93 Mn | 11.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.50 Mn |
| Mar 31, 2026 | -8.50 Mn |
| Dec 31, 2025 | -2.18 Mn |
| Dec 31, 2025 | -2.18 Mn |
| Sep 30, 2025 | -7.30 Mn |
| Sep 30, 2025 | -7.30 Mn |
| Jun 30, 2025 | -5.00 Mn |
| Jun 30, 2025 | -5.00 Mn |